| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/08/2012 | EP2483277A1 Benzoxepin pi3k inhibitor compounds and methods of use |
| 08/08/2012 | EP2483272A2 Pi3k (delta) selective inhibitors |
| 08/08/2012 | EP2483271A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 08/08/2012 | EP2483269A2 Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| 08/08/2012 | EP2483268A1 Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases |
| 08/08/2012 | EP2483263A1 Novel compounds that are erk inhibitors |
| 08/08/2012 | EP2483259A1 Irreversible inhibitors useful for the treatment of kinase-related pathologies |
| 08/08/2012 | EP2483253A2 Compounds as lysophosphatidic acid receptor antagonists |
| 08/08/2012 | EP2483252A2 Compounds as lysophosphatidic acid receptor antagonists |
| 08/08/2012 | EP2483251A2 Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| 08/08/2012 | EP2483249A1 Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors |
| 08/08/2012 | EP2483240A2 1-desoxy-2-methylene-19-nor-vitamin d analogs and their uses |
| 08/08/2012 | EP2482849A2 Combination immunotherapy for the treatment of cancer |
| 08/08/2012 | EP2482842A1 Cancer therapy |
| 08/08/2012 | EP2482827A1 Antioxidants for use in therapy |
| 08/08/2012 | EP2482821A1 Crystalline hydrochloride salts of c-met kinase inhibitors |
| 08/08/2012 | EP2482820A2 New use of pdgfrbeta inhibitors |
| 08/08/2012 | EP2482819A2 Combination |
| 08/08/2012 | EP2200612B1 Inhibitors of janus kinases |
| 08/08/2012 | EP2190447B1 His-Pro-Gly-Ser-Arg-lle-Val-Leu-Ser-Leu-Asp-Val-Pro-lle-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-ile-Leu-Ala-Arg-Val-NH2 for use in anti-angiogenic therapy |
| 08/08/2012 | EP2189161B1 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent |
| 08/08/2012 | EP2187901B1 Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy |
| 08/08/2012 | EP2182966B1 The use of extracts or materials extracted from piper cubeba l. as an effective component in a drug for the treatment of cancer diseases |
| 08/08/2012 | EP2181990B1 Piperidine derivative |
| 08/08/2012 | EP2152753B1 Antibodies against ramp3 |
| 08/08/2012 | EP2152369B1 Use of fluoride-containing compounds for diagnostic purposes with the help of imaging processes |
| 08/08/2012 | EP2121693B1 8-oxoadenine derivatives as immuno-modulators |
| 08/08/2012 | EP2118318B1 Gnaq mutations in melanoma |
| 08/08/2012 | EP2066680B1 Triphenylphosphonium thionitrite nitric oxide donors |
| 08/08/2012 | EP1945631B1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 08/08/2012 | EP1890537B1 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
| 08/08/2012 | EP1793823B1 Phosphate containing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents |
| 08/08/2012 | EP1169038B1 Cyclic protein tyrosine kinase inhibitors |
| 08/08/2012 | EP1127148B1 Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 08/08/2012 | EP0837938B1 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 08/08/2012 | CN1930288B Cells of which genome is modified |
| 08/08/2012 | CN1439375B Dehydroepiandrosterone treating use and transfer system |
| 08/08/2012 | CN102630229A Treating notch1-antagonist-resistant cancer (s) using notch3 antagonists |
| 08/08/2012 | CN102630175A Medical use of SPLA2 hydrolysable liposomes |
| 08/08/2012 | CN102628074A Proteolysis resistant antibody preparations |
| 08/08/2012 | CN102628047A Nucleic acid aptamer rich in guanine and application thereof |
| 08/08/2012 | CN102628046A Nucleic acid aptamer rich in guanine |
| 08/08/2012 | CN102627767A Potential of hydrogen (pH) response random copolymer based on poly-beta amino ester and preparation method and application thereof |
| 08/08/2012 | CN102627685A Nitric oxide-donating glutathione compound, preparation method and medical purpose thereof |
| 08/08/2012 | CN102627683A Triterpenoid saponin compounds with antitumor effects |
| 08/08/2012 | CN102627682A Esterified and halogenated stigmasterol derivate and application thereof in anti-cancer drugs |
| 08/08/2012 | CN102627670A Aryl alkyl acid-cyclophosphamide derivative as well as preparation method and application thereof |
| 08/08/2012 | CN102627658A Organic compounds |
| 08/08/2012 | CN102627650A Chiral spiro(pyrrolidine-3, 2'-oxindole)compound and synthesis method thereof |
| 08/08/2012 | CN102627649A Small molecule inhibitors of MDM2 and uses thereof |
| 08/08/2012 | CN102627645A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 08/08/2012 | CN102627642A Metal complexes of moxifloxacin and pharmaceutical purpose thereof |
| 08/08/2012 | CN102627640A Heterobicyclic compounds useful as p38 kinase inhibiting agents |
| 08/08/2012 | CN102627632A Amino quinazoline derivative and preparation method as well as application thereof |
| 08/08/2012 | CN102627620A One type of benzofuran derivatives and medical application thereof |
| 08/08/2012 | CN102627614A Diquinazoline diselenide compound as well as preparation method and bioactivity thereof |
| 08/08/2012 | CN102627613A 2-[(4,6-dimethyl pyrimidine-2-)oxyl]-3-cyano-3,3-dibenzyl propionic acid optical isomer, its preparation method and medical application |
| 08/08/2012 | CN102627611A Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one |
| 08/08/2012 | CN102627610A One type of benzimidazole derivatives and application thereof |
| 08/08/2012 | CN102627604A Two types of isoquinoline compounds and application thereof to preparing anti-cancer medicaments |
| 08/08/2012 | CN102627597A Indole-3-carboxaldehyde isobutyryl hydrazone derivatives and preparation method thereof |
| 08/08/2012 | CN102627593A 1,4-dihydroxy-2-formyl-9,10 anthraquinone thiosemicarbazone new compound with anticancer activity and preparation method thereof |
| 08/08/2012 | CN102627267A Fullerene polysaccharide derivative and its preparation method |
| 08/08/2012 | CN102626522A Polypeptide radioactive diagnosis and treatment medicament based on chemotactic factor receptor CXCR4 polypeptide antagonist |
| 08/08/2012 | CN102626521A Segmented copolymer - docetaxel combination, preparation thereof and preparation method thereof |
| 08/08/2012 | CN102626508A Traditional Chinese medicine composite for curing liver cancer |
| 08/08/2012 | CN102626507A Traditional Chinese medicine for curing uterine fibroid |
| 08/08/2012 | CN102626469A Method for preparing high-purity tea polyphenol in centrifuging, extracting and separating mode |
| 08/08/2012 | CN102626460A Preparation method of Zanthoxylum dissitum Hemsl skin polysaccharide and application |
| 08/08/2012 | CN102626452A Hawthorn, radix puerariae, gingko and balsam pear four-in-one flavone capsule |
| 08/08/2012 | CN102626448A Method for extracting total alkaloids from thalictrum plants |
| 08/08/2012 | CN102626434A Preparing method for separating and purifying flavonoid compounds from micropore grass seed dregs |
| 08/08/2012 | CN102626432A Method for extracting alkaloid from tylophora |
| 08/08/2012 | CN102626429A Method for water-bath extraction of castanea mollissina Blume involucre polyphenols |
| 08/08/2012 | CN102626426A Anti-tumor compound poria cocos preparation and preparation method thereof |
| 08/08/2012 | CN102626416A Application of tamoxifen, rapamycin and ginsenoside Rg3 composition in preparing medicaments for treating liver cancer |
| 08/08/2012 | CN102626413A Application of phenoxyl pyridine derivative |
| 08/08/2012 | CN102626412A Pharmaceutical composition for curing malignant tumor |
| 08/08/2012 | CN102626405A Application of paclitaxel in preparation of medicament for treatment of EGFR-TKI acquired resistance |
| 08/08/2012 | CN102626399A Calcium alginate microcapsule, preparation method and application thereof |
| 08/08/2012 | CN102626393A Albumin nanometer particle preparation for soluble injection and preparation method of albumin nanometer particle preparation |
| 08/08/2012 | CN102626384A Curcumin suspension and preparation method thereof |
| 08/08/2012 | CN102423416B Medicament combination for preventing or treating stomach cancer |
| 08/08/2012 | CN102225122B Caffeine-free tea polyphenol and preparation method thereof |
| 08/08/2012 | CN102204974B Compound Chinese actinidia root Chinese medicinal composition and preparation method and application thereof |
| 08/08/2012 | CN102188644B Traditional Chinese medicine for treating cancers |
| 08/08/2012 | CN102178818B Traditional Chinese medicinal composition for treating breast cancer and preparation method thereof |
| 08/08/2012 | CN102178701B Preparation method of polysaccharide composite with antitumor activity |
| 08/08/2012 | CN102167718B 16-imidazole substitute-3amine substitute-5 alpha androstane derivatives and preparation method and application thereof |
| 08/08/2012 | CN102145030B Kiwi soft capsule preparation method with functions of regulating immunity and inhibiting tumors |
| 08/08/2012 | CN102085293B Liriope muscari extract with anti-tumor action and preparation method thereof |
| 08/08/2012 | CN102040578B Method for preparing high purity tricin from bamboo leaves |
| 08/08/2012 | CN102000047B Antrodia camphorata cyclonene compound for restraining growth of bone cancer cells |
| 08/08/2012 | CN101935651B siRNA module of targeted Survivin gene and application thereof |
| 08/08/2012 | CN101935649B SiRNA (Small Interfering RNA) molecule capable of suppressing Survivin expression and application thereof |
| 08/08/2012 | CN101928747B Application of E3 ubiquitin ligase CHIP in gliomatosis cerebri disease |
| 08/08/2012 | CN101920009B Vaccine for preventing and curing tumor |
| 08/08/2012 | CN101892235B MicroRNA used for inducing leukemia cell differentiation |
| 08/08/2012 | CN101885784B Method for producing glucomannan by liquid culture of konjac cells |
| 08/08/2012 | CN101851251B Dibutyltin (IV) complex for acyl hydrazone Schiff-base ligand and preparation method and application thereof |